z-logo
open-access-imgOpen Access
In-vivo MRI Reveals Changes to Intracerebral Vasculature Caliber in HIV Infection
Author(s) -
Paba M. De Alwis,
Bryan Smith,
Tianxia Wu,
Cristah Artrip,
Sally Steinbach,
Caryn G. Morse,
ChuenYen Lau,
Stanley I. Rapoport,
Joseph Snow,
Edmund C. Tramont,
Daniel S. Reich,
Govind Nair,
Avindra Nath
Publication year - 2019
Publication title -
frontiers in neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 67
ISSN - 1664-2295
DOI - 10.3389/fneur.2019.00687
Subject(s) - caliber , medicine , magnetic resonance imaging , cardiology , human immunodeficiency virus (hiv) , cohort , cerebrospinal fluid , in vivo , gastroenterology , pathology , immunology , radiology , biology , materials science , microbiology and biotechnology , metallurgy
Objective: To characterize cerebral arterial remodeling in HIV-infected (HIV+) individuals in-vivo , and to study its clinical and immunological associations. Methods: T2 * -weighted magnetic resonance imagining sequences was used to determine cross-sectional area (vascular caliber) of the anterior (A1 segment) and middle (M1 segment) cerebral arteries in HIV- (control) and HIV+ subjects on antiretroviral therapy. Correlations of A1 caliber with clinical, demographic parameters, and immunological markers in cerebrospinal fluid (CSF) were determined using multivariable analyses. Results: A1 and M1 calibers from 22 HIV- control subjects (age: median 48.5 years, range 22-60 years, 55% male) and 61 HIV+ subjects (age: median 53 years, range 25–60 years, 67% male) were studied. ANCOVA, adjusting for ethnicity and sex (age was not correlated with M1 or A1 caliber in either group), revealed that HIV+ subjects had larger caliber in the A1 segment than HIV- subjects (4.95 ± 0.14 mm 2 , and 4.47 ± 0.21 mm 2 respectively, p = 0.048), but caliber of the M1 segment did not differ among the groups (7.21 ± 0.14 mm 2 and 7.09 ± 0.23 mm 2 respectively, p = 0.65). In the HIV+ cohort, longer disease duration and higher current CD4 T-cell count were associated with reduced A1 caliber ( r =−0.42 and −0.33 respectively, p < 0.05). In addition, increase in cardiovascular disease risk (CVD risk) was associated with a decrease in A1 caliber in the HIV group ( r = −0.35, p < 0.05). Conclusions: This cross-sectional study reveals an increase in A1 caliber in the HIV+ cohort, compared to control subjects, which is especially prominent in early phase of the disease. This increase in caliber may be associated with acute pathological processes in HIV during the initial stages of infection resulting in loss of compliance or thinning of the arterial wall. At later stages, such changes may be confounded by arteriosclerotic changes that are common in later stages of HIV infection. This study suggests there is extensive vessel remodeling in various stages of infection. Long-term longitudinal follow-up of this cohort is planned to further verify this hypothesis and to better understand this MRI marker of intracranial vascular caliber.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom